spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Famvir 

 HSMN NewsFeed - 5 Dec 2011
TOPICA Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2008
Teva Completes Acquisition of Bentley Pharmaceuticals
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2008
Teva to Acquire Barr
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2008
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Biopharmaceuticals Generics Neurology FDA Litigation
 HSMN NewsFeed - 1 Jul 2008
Teva Provides Update on Generic Seroquel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jun 2008
Teva Announces Tentative Approval of Generic Diovan(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2008
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Apr 2008
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Apr 2008
Teva Announces Approval of Generic Flolan(R) for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Apr 2008
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Apr 2008
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2008
Teva Provides Update on Generic Prevacid(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
Teva to Acquire Bentley Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Mar 2008
Teva Provides Update on Generic Aricept(R) Litigation
Biopharmaceuticals Generics Litigation Neurology
 HSMN NewsFeed - 13 Mar 2008
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Feb 2008
Teva Provides Update on Generic Actonel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Feb 2008
Teva Announces Approval of Generic Camptosar(R)
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 1 Feb 2008
Teva Provides Update on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 29 Jan 2008
Teva Announces Wyeth Voids Standstill Agreement on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Jan 2008
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jan 2008
Teva to Acquire CoGenesys
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2008
Teva Announces Tentative Approval of Generic Aricept(R) Tablets
Biopharmaceuticals Generics FDA Neurology
 HSMN NewsFeed - 14 Jan 2008
Teva to Explore Strategic Alternatives for its Animal Health Business
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2008
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Teva Announces Approval of Generic Kytril(R) Injection and Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jan 2008
Teva Announces Approval of Generic DuoNeb
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Dec 2007
Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 12 Dec 2007
Teva Announces Approval of Generic Trileptal(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Dec 2007
Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Nov 2007
Teva Announces Tentative Approval of Generic Requip(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Nov 2007
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2007
Teva Announces Planned Retirement of CFO Dan Suesskind in Mid-2008
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2007
COPAXONE(R) Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Oct 2007
Adenoscan(R) Patent Lawsuits Settled
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2007
Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Teva Announces Approval of Generic Actonel(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 5 Oct 2007
Teva Announces Tentative Approval of Generic Valtrex(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Sep 2007
Teva Announces Settlement of Generic Avandia(R), Avandamet(R), and Avandaryl(R) Litigation with GlaxoSmithKline
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Sep 2007
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
Teva Receives Positive Feedback on Second AOK Tender in Germany
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2007
Teva Provides Update on Generic Famvir(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2007
Teva Announces Launch of Generic Famvir(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Sep 2007
Teva Receives Favorable Court Decision Regarding Generic Famvir(R) Tablets; Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Aug 2007
Teva Announces Approval of Generic Famvir(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Sep 2006
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Famvir
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!